Unscripted the AMCP Podcast: PVEK and the Changing Treatment Landscape for BPDCN
Healthcare NOW Radio Podcast Network - Discussions on healthcare including technology, innovation, policy, data security, telehealth and more. Visit HealthcareNOWRadio.com
- Published
- September 9, 2026
- Duration
- 21:04
- Summary source
- description
- Last updated
- Sep 23, 2026
Discusses PVEK and the Changing Treatment Landscape for BPDCN On this episode host Dr. Ryan Haumschild, Vice P…
Summary
PVEK and the Changing Treatment Landscape for BPDCN On this episode host Dr. Ryan Haumschild, Vice President of Pharmacy at Emory, is joined by Dr. Naveen Pemmaraju, Professor of Leukemia and founding director of the BPDCN program at MD Anderson, to discuss blastic plasmacytoid dendritic cell neoplasm (BPDCN), an ultra-rare and aggressive blood cancer. Th…
Intelligent Report
Sign in to read teasers, or upgrade to Research Pro to commission intelligent report for this episode. Learn more →
Show notes
PVEK and the Changing Treatment Landscape for BPDCN On this episode host Dr. Ryan Haumschild, Vice President of Pharmacy at Emory, is joined by Dr. Naveen Pemmaraju, Professor of Leukemia and founding director of the BPDCN program at MD Anderson, to discuss blastic plasmacytoid dendritic cell neoplasm (BPDCN), an ultra-rare and aggressive blood cancer. They examine the recent FDA approval of pivekimab sunirine-pvzy (PVEK), a CD123-directed antibody-drug conjugate, and results from the CADENZA tr